CVS Health Corporation Financial Statements (CVS)
|
|
|
|
Report date
|
|
|
09.02.2022 |
08.02.2023 |
07.02.2024 |
12.02.2025 |
10.02.2026 |
|
06.05.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
292 111 |
322 467 |
357 776 |
372 809 |
402 067 |
|
407 905 |
|
Operating Income, bln rub |
|
|
13 310 |
7 954 |
13 743 |
8 516 |
10 385 |
|
5 966 |
|
EBITDA, bln rub |
? |
|
17 526 |
12 347 |
18 197 |
13 683 |
9 861 |
|
11 132 |
|
Net profit, bln rub |
? |
|
8 001 |
4 311 |
8 344 |
4 614 |
1 768 |
|
2 932 |
|
|
OCF, bln rub |
? |
|
18 265 |
16 177 |
13 426 |
9 107 |
10 639 |
|
10 332 |
|
CAPEX, bln rub |
? |
|
2 520 |
2 727 |
3 031 |
2 781 |
2 832 |
|
2 938 |
|
FCF, bln rub |
? |
|
15 745 |
13 450 |
10 395 |
6 326 |
7 807 |
|
7 394 |
|
Dividend payout, bln rub
|
|
|
2 625 |
2 907 |
3 132 |
3 373 |
3 397 |
|
3 404 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
32.8% |
67.4% |
37.5% |
73.1% |
192.1% |
|
116.1% |
|
|
OPEX, bln rub |
|
|
38 810 |
46 548 |
40 688 |
42 885 |
44 977 |
|
50 624 |
|
Cost of production, bln rub |
|
|
239 991 |
267 965 |
303 345 |
321 408 |
346 705 |
|
351 315 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
2 503 |
2 287 |
2 658 |
2 958 |
3 119 |
|
3 108 |
|
|
Assets, bln rub |
|
|
232 999 |
228 275 |
249 728 |
253 215 |
261 064 |
|
252 974 |
|
Net Assets, bln rub |
? |
|
75 075 |
71 469 |
76 461 |
75 560 |
75 214 |
|
77 456 |
|
Debt, bln rub |
|
|
75 999 |
70 732 |
79 385 |
82 920 |
93 593 |
|
78 345 |
|
Cash, bln rub |
|
|
12 525 |
15 723 |
11 455 |
10 993 |
10 657 |
|
11 802 |
|
Net debt, bln rub |
|
|
63 474 |
55 009 |
67 930 |
71 927 |
82 936 |
|
66 543 |
|
|
Ordinary share price, rub |
|
|
103.2 |
93.2 |
79.0 |
44.9 |
79.4 |
|
96.5 |
|
Number of ordinary shares, mln |
|
|
1 319 |
1 312 |
1 285 |
1 259 |
1 267 |
|
1 273 |
|
|
Market cap, bln rub |
|
|
136 068 |
122 265 |
101 464 |
56 517 |
100 549 |
|
122 845 |
|
EV, bln rub |
? |
|
199 542 |
177 274 |
169 394 |
128 444 |
183 485 |
|
189 388 |
|
Book value, bln rub |
|
|
-33 072 |
-31 484 |
-44 045 |
-43 035 |
-35 772 |
|
-33 092 |
|
|
EPS, rub |
? |
|
6.07 |
3.29 |
6.49 |
3.66 |
1.40 |
|
2.30 |
|
FCF/share, rub |
|
|
11.9 |
10.3 |
8.09 |
5.02 |
6.16 |
|
5.81 |
|
BV/share, rub |
|
|
-25.1 |
-24.0 |
-34.3 |
-34.2 |
-28.2 |
|
-26.0 |
|
|
EBITDA margin, % |
? |
|
6.00% |
3.83% |
5.09% |
3.67% |
2.45% |
|
2.73% |
|
Net margin, % |
? |
|
2.74% |
1.34% |
2.33% |
1.24% |
0.44% |
|
0.72% |
|
FCF yield, % |
? |
|
11.6% |
11.0% |
10.2% |
11.2% |
7.76% |
|
6.02% |
|
ROE, % |
? |
|
10.7% |
6.03% |
10.9% |
6.11% |
2.35% |
|
3.79% |
|
ROA, % |
? |
|
3.43% |
1.89% |
3.34% |
1.82% |
0.68% |
|
1.16% |
|
|
P/E |
? |
|
17.0 |
28.4 |
12.2 |
12.2 |
56.9 |
|
41.9 |
|
P/FCF |
|
|
8.64 |
9.09 |
9.76 |
8.93 |
12.9 |
|
16.6 |
|
P/S |
? |
|
0.47 |
0.38 |
0.28 |
0.15 |
0.25 |
|
0.30 |
|
P/BV |
? |
|
-4.11 |
-3.88 |
-2.30 |
-1.31 |
-2.81 |
|
-3.71 |
|
EV/EBITDA |
? |
|
11.4 |
14.4 |
9.31 |
9.39 |
18.6 |
|
17.0 |
|
Debt/EBITDA |
|
|
3.62 |
4.46 |
3.73 |
5.26 |
8.41 |
|
5.98 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
0.86% |
0.85% |
0.85% |
0.75% |
0.70% |
|
0.72% |
|
| CVS Health Corporation shareholders |
